SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-21-007858
Filing Date
2021-11-12
Accepted
2021-11-12 07:01:47
Documents
65
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q apto20210930_10q.htm   iXBRL 10-Q 979191
2 EXHIBIT 31.1 ex_304443.htm EX-31.1 11882
3 EXHIBIT 31.2 ex_304444.htm EX-31.2 12139
4 EXHIBIT 32.1 ex_304445.htm EX-32.1 3650
5 EXHIBIT 32.2 ex_304446.htm EX-32.2 3781
11 apto20210930_10qimg001.gif GRAPHIC 4337
  Complete submission text file 0001171843-21-007858.txt   4692305

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA apto-20210930.xsd EX-101.SCH 46675
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apto-20210930_cal.xml EX-101.CAL 31405
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apto-20210930_def.xml EX-101.DEF 281177
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE apto-20210930_lab.xml EX-101.LAB 260522
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apto-20210930_pre.xml EX-101.PRE 310137
12 EXTRACTED XBRL INSTANCE DOCUMENT apto20210930_10q_htm.xml XML 752250
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32001 | Film No.: 211399464
SIC: 2836 Biological Products, (No Diagnostic Substances)